Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitlePharmacologic screen identifies active combinations with BET inhibitors and LRRK2 as a novel putative target in lymphoma.AuthorsSpriano, Filippo; Sartori, Giulio; Tarantelli, Chiara; Barreca, Marilia; Golino, Gaetanina; Rinaldi, Andrea; Napoli, Sara; Mascia, Michele; Scalise, Lorenzo; Arribas, Alberto J.; Cascione, Luciano; Zucca, Emanuele; Stathis, Anastasios; Gaudio, Eugenio; Bertoni, FrancescoPublicationEJHaem, 2022, Vol 3, Issue 3, p764Publication typeArticleDOI10.1002/jha2.535